Table 2.
Summary of the PhosphoScan-SILAC results for H3255 treated with gefitinib and for MKN45 treated with Su11274
| H3255 (gefitinib) |
MKN45 (Su11274) |
|||||
|---|---|---|---|---|---|---|
| 3-h and 24-h combined | 3-h | 24-h | 3-h and 24-h combined | 3-h | 24-h | |
| p-Peptides | 393 | 308 | 337 | 1181 | 976 | 903 |
| p-Proteins | 185 | 160 | 167 | 535 | 469 | 447 |
| p-Sites | 301 | 245 | 267 | 945 | 793 | 756 |
| Sites affected >2.5-fold | 110 | 161 | 586 | 603 | ||
| Sites affected >5-fold | 84 | 133 | 423 | 462 | ||